SIERRA ONCOLOGY INC's ticker is SRRA and the CUSIP is 82640U107. A total of 63 filers reported holding SIERRA ONCOLOGY INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $910,000 | -12.6% | 2,666,190 | 0.0% | 0.02% | -35.7% |
Q3 2019 | $1,041,000 | -30.3% | 2,666,190 | 0.0% | 0.03% | -17.6% |
Q2 2019 | $1,493,000 | -67.3% | 2,666,190 | 0.0% | 0.03% | -73.6% |
Q1 2019 | $4,559,000 | +33.6% | 2,666,190 | 0.0% | 0.13% | -0.8% |
Q4 2018 | $3,413,000 | -37.3% | 2,666,190 | -16.7% | 0.13% | -10.3% |
Q3 2018 | $5,440,000 | -59.2% | 3,200,000 | -28.9% | 0.14% | -58.5% |
Q2 2018 | $13,320,000 | +28.7% | 4,500,000 | -10.0% | 0.35% | +20.3% |
Q1 2018 | $10,350,000 | -44.5% | 5,000,000 | 0.0% | 0.29% | -53.1% |
Q4 2017 | $18,650,000 | +64.6% | 5,000,000 | -31.6% | 0.62% | +186.1% |
Q3 2017 | $11,332,000 | +165.0% | 7,310,372 | +100.0% | 0.22% | +0.5% |
Q2 2017 | $4,277,000 | -24.5% | 3,655,186 | -1.3% | 0.22% | -33.4% |
Q1 2017 | $5,667,000 | – | 3,703,704 | – | 0.32% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
FRAZIER MANAGEMENT LLC | 8,112,121 | $13,872,000 | 3.34% |
New Leaf Venture Partners, L.L.C. | 5,020,446 | $8,585,000 | 2.35% |
Abingworth LLP | 1,365,027 | $2,307,000 | 2.06% |
Prosight Management, LP | 2,457,683 | $4,203,000 | 1.84% |
Broadfin Capital, LLC | 4,829,832 | $8,259,000 | 1.70% |
MANGROVE PARTNERS IM, LLC | 3,688,609 | $6,308,000 | 0.84% |
Vivo Capital, LLC | 2,438,270 | $4,169,000 | 0.42% |
683 Capital Management, LLC | 2,313,159 | $3,956,000 | 0.36% |
PA Capital LLC | 138,082 | $236,000 | 0.25% |
ARMISTICE CAPITAL, LLC | 1,560,000 | $2,668,000 | 0.15% |